Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05879406 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne
A NA study, sponsored by Ablon Skin Institute Research Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05879406 is a NA study that has completed, run by Ablon Skin Institute Research Center. The registered enrollment target is 40 participants.
The verdict
NCT05879406, a NA study, has completed, sponsored by Ablon Skin Institute Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare Clear Skin Fomula Supplement to Placebo in healthy men and women ages 18-40 to mitigate mild to moderate non-cystic acne over the course of 12 weeks. Participants will be asked to take a daily supplement, have photos of their face taken and answer questionnaires related to their acne.
Interventions
- OTHER Placebo Capsules
- DIETARY_SUPPLEMENT VitaMedica® Clear Skin Formula capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-05-31 |
| Est. Completion | 2024-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05879406
The ClinicalTrials.gov registry entry for NCT05879406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ablon Skin Institute Research Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Capsules is the first listed.
NCT05879406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05879406 about?
NCT05879406 is a clinical study titled "A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne". The goal of this clinical trial is to compare Clear Skin Fomula Supplement to Placebo in healthy men and women ages 18-40 to mitigate mild to moderate non-cystic acne over the course of 12 weeks. Participants will be asked to take a daily supplement, have photos of their face taken and answer questi...
What is the current status of trial NCT05879406?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-05-31. Estimated completion is 2024-01-23.
What interventions are being tested in trial NCT05879406?
The interventions under investigation include: Placebo Capsules (OTHER), VitaMedica® Clear Skin Formula capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05879406?
This trial is sponsored by Ablon Skin Institute Research Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.